Researchers
Savić, Miroslav
Issue Date | Title | Author(s) | Type | М-cat. |
---|---|---|---|---|
2024 | Overcoming the low solubility of novel pyrazoloquinolinone ligand (CW-02-79) by combination of drug-phospholipid complex and nanoemulsion technology: design and physicochemical evaluation | Stanković, Tijana ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Other | Mp. category will be shown later |
2023 | Farmakologija (✓) | Stepanović-Petrović, Radica ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Text book | Mp. category will be shown later |
2023 | Farmakoterapija za farmaceute (✓) | Ugrešić, Nenad ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Text book | Mp. category will be shown later |
2022 | Neuroimmune aspects of mood, anxiety and cognitive effects of leads/drug candidates acting at GABAA and/or sigma-2 receptors: In vitro/in vivo delineation by nano- and hiPSC-based platforms | Savić, Snežana ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Other | Mp. category will be shown later |
2016 | Farmakoterapija za farmaceute (✓) | Ugrešić, Nenad ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Text book | Mp. category will be shown later |
2014 | Farmakoterapija za farmaceute (✓) | Savić, Miroslav M. ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Text book | Mp. category will be shown later |
2004 | Izveštaj sa 24. kongresa Collegium Internationale Neuropsychopharmacologicum (CINP) | Savić, Miroslav M. ![]() ![]() | Other | Mp. category will be shown later |